John A Scarlett - Net Worth and Insider Trading
John A Scarlett Net Worth
The estimated net worth of John A Scarlett is at least $3 Million dollars as of 2024-11-29. John A Scarlett is the Chairman, President and CEO of Geron Corp and owns about 600,000 shares of Geron Corp (GERN) stock worth over $3 Million. Details can be seen in John A Scarlett's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that John A Scarlett has not made any transactions after 2024-06-04 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of John A Scarlett
John A Scarlett Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, John A Scarlett owns 3 companies in total, including CytomX Therapeutics Inc (CTMX) , Chiasma Inc (CHMA) , and Geron Corp (GERN) .
Click here to see the complete history of John A Scarlett’s form 4 insider trades.
Insider Ownership Summary of John A Scarlett
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CTMX | CytomX Therapeutics Inc | 2018-06-13 | director |
| CHMA | Chiasma Inc | 2020-06-11 | director |
| GERN | Geron Corp | 2024-06-04 | director & Chief Executive Officer |
John A Scarlett Latest Holdings Summary
John A Scarlett currently owns a total of 1 stock. John A Scarlett owns 600,000 shares of Geron Corp (GERN) as of June 4, 2024, with a value of $3 Million.
Latest Holdings of John A Scarlett
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| GERN | Geron Corp | 2024-06-04 | 600,000 | 4.17 | 2,502,000 |
Holding Weightings of John A Scarlett
John A Scarlett Form 4 Trading Tracker
According to the SEC Form 4 filings, John A Scarlett has made a total of 2 transactions in Geron Corp (GERN) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Geron Corp is the sale of 600,000 shares on June 4, 2024, which brought John A Scarlett around $2 Million.
Insider Trading History of John A Scarlett
- 1
John A Scarlett Trading Performance
GuruFocus tracks the stock performance after each of John A Scarlett's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by John A Scarlett is 33.65%. GuruFocus also compares John A Scarlett's trading performance to market benchmark return within the same time period. The performance of stocks bought by John A Scarlett within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how John A Scarlett's insider trading performs compared to the benchmark.
Performance of John A Scarlett
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 1.92 | | | | | |
| Relative Return to S&P 500(%) | 0.61 | | | | | |
John A Scarlett Ownership Network
John A Scarlett Owned Company Details
What does CytomX Therapeutics Inc do?
Who are the key executives at CytomX Therapeutics Inc?
John A Scarlett is the director of CytomX Therapeutics Inc. Other key executives at CytomX Therapeutics Inc include SVP & Chief Scientific Officer Marcia Belvin , SVP & Finance and Accounting Christopher Ogden , and Chief Financial Officer Jeffrey B Landau .
CytomX Therapeutics Inc (CTMX) Insider Trades Summary
Over the past 18 months, John A Scarlett made no insider transaction in CytomX Therapeutics Inc (CTMX). Other recent insider transactions involving CytomX Therapeutics Inc (CTMX) include a net sale of 62,273 shares made by Sean A. Mccarthy , a net sale of 25,172 shares made by Marcia Belvin , and a net sale of 19,012 shares made by Lloyd A Rowland .
In summary, during the past 3 months, insiders sold 0 shares of CytomX Therapeutics Inc (CTMX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 132,341 shares of CytomX Therapeutics Inc (CTMX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 132,341 shares.
CytomX Therapeutics Inc (CTMX)'s detailed insider trading history can be found in Insider Trading Tracker table.
CytomX Therapeutics Inc Insider Transactions
John A Scarlett Mailing Address
Above is the net worth, insider trading, and ownership report for John A Scarlett. You might contact John A Scarlett via mailing address: C/o Geron Corporation, 230 Constitution Drive, Menlo Park Ca 94025.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
